Printer Friendly

Shimadzu and Kobe University Jointly Identify Key Proteins in Kidney Cancer.

Tokyo, Japan, June 15, 2006 - (JCN) - Shimadzu Corporation has discovered several types of protein that may play a role in the diagnosis and treatment of kidney cancer in collaboration with Kobe University.

Using Shimadzu's proprietary NBS (2-nitrobenzensulfenyl) reagents, the two partners have discovered 106 different types of protein in cancer cells and 28 different types of protein in normal cells, and identified the structures of these proteins.

The partners plan to proceed with research on the newly identified proteins, in particular those that increase in cancer cells, aiming to elucidate a mechanism and develop a method to treat kidney cancer.

Details of the research will be presented at the 20th IUBMB International Congress of Biochemistry and Molecular Biology to be held this month and the 23rd Annual Meeting of the Japan Society for Therapeutic Drug Monitoring to be held in July.

Copyright [c] 2006 Japan Corporate News Network. All rights reserved.
COPYRIGHT 2006 Japan Corporate News Network K.K.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 
Article Details
Printer friendly Cite/link Email Feedback
Publication:JCNN News Summaries
Geographic Code:9JAPA
Date:Jun 16, 2006
Words:151
Previous Article:Sanyo Electric, Institut Technologi Bandung to Collaborate in Developing Water Purification Solution.
Next Article:Ono Pharmaceutical, Banyu Pharmaceutical Jointly Confirm Hypoglycemic Effect of DPP4 Inhibitor Sitagliptin.
Topics:


Related Articles
Paring protein: low-protein cuisines may slow aging.
Cancer: pare protein to spare the kidneys.
SHAMAN PRODUCTS POISED TO PREVENT MULTIPLE FORMS OF CANCER.
Anticancer Protein Locks onto DNA.
Protein flags colon, prostate cancers. (Cancer).
MATRITECH/SYSMEX TO DEVELOP AUTOMATED PAP SMEAR TEST.
Brain cancer patients short on valuable protein.
Mitochondria genes may influence cancer risk.
Shimadzu Launches Reagent Kit for N-terminal Amino Acid Sequencing Analysis.
Shimadzu, Central Research Laboratory to Unveil Protein that Spreads Cancer.

Terms of use | Privacy policy | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters